https://peptide-solubility.com..../a-longitudinal-exam
We now have, for the first time, discovered that Trx1 and telomerase had a dual-target synergistic effect. Centered on that results, we designed a series of 6-dithio-2'-deoxyguanosine analogs (named as YLS00X) and verified whether or not they can inhibit Trx1 and telomerase simultaneously. TrxR1/Trx1 system task and telomerase phrase had been dramatically inhibited by 6-dithio-2'-deoxyguanosine analogs, specifically YLS004. YLS004 may also cause ROS accumulation, and induce tumefaction c
Like
Comment
Share
